Antiepileptic Drugs in Elderly Patients

Last updated: July 14, 2022
Sponsor: Wei Zhao
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT05459597
Elderly-Antiepileptic Drugs
  • Ages 65-100
  • All Genders

Study Summary

The purpose is to study the population pharmacokinetics, effectiveness and safety of antiepileptic drug (phenytoin, carbamazepine, lamotrigine, levetiracetam, parempanel, etc) in elderly patients and recommend optimized dosage regimens.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age ≥65 years old;
  2. Diagnosed with epilepsy;
  3. Using antiepileptic drugs for treatment;

Exclusion

Exclusion Criteria:

  1. Patients who are expected to die within 48 hours;
  2. Patients with allergy to antiepileptic drugs;
  3. Patients receiving other investigational drugs;
  4. Other factors that the researcher considers unsuitable for inclusion.

Study Design

Total Participants: 500
Study Start date:
January 01, 2021
Estimated Completion Date:
June 30, 2028

Connect with a study center

  • Wei Zhao

    Jinan, Shandong
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.